These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6088690)

  • 41. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors.
    Bischoff S; Heinrich M; Sonntag JM; Krauss J
    Eur J Pharmacol; 1986 Oct; 129(3):367-70. PubMed ID: 3536532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of acute and subacute administration of bicuculline on dopamine and muscarinic receptors in rat brain.
    Lim DK; Ito Y; Hoskins B; Ho IK
    Brain Res Bull; 1988 Jul; 21(1):21-4. PubMed ID: 3064880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
    Luthin GR; Wolfe BB
    Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations in neurotransmitter receptors and glucose use after unilateral orbital enucleation.
    Chalmers DT; McCulloch J
    Brain Res; 1991 Feb; 540(1-2):243-54. PubMed ID: 1675915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics.
    Mita T; Hanada S; Nishino N; Kuno T; Nakai H; Yamadori T; Mizoi Y; Tanaka C
    Biol Psychiatry; 1986 Dec; 21(14):1407-14. PubMed ID: 2947636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscarinic cholinergic receptors in human infant forebrain: [3H]quinuclidinyl benzilate binding in homogenates and quantitative autoradiography in sections.
    Johnston MV; Silverstein FS; Reindel FO; Penney JB; Young AB
    Brain Res; 1985 Apr; 351(2):195-203. PubMed ID: 3995346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography.
    Altar CA; O'Neil S; Walter RJ; Marshall JF
    Science; 1985 May; 228(4699):597-600. PubMed ID: 2580352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and localization of serotonin receptors in human brain postmortem.
    Biegon A; Kargman S; Snyder L; McEwen BS
    Brain Res; 1986 Jan; 363(1):91-8. PubMed ID: 2936426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
    De Souza EB
    Endocrinology; 1986 Oct; 119(4):1534-42. PubMed ID: 2944737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the receptor profile of bisoprolol.
    Klockow M; Greiner HE; Haase A; Schmitges CJ; Seyfried C
    Arzneimittelforschung; 1986 Feb; 36(2):197-200. PubMed ID: 2870719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of acute and chronic cholinesterase inhibition with diisopropylfluorophosphate on muscarinic, dopamine, and GABA receptors of the rat striatum.
    Sivam SP; Norris JC; Lim DK; Hoskins B; Ho IK
    J Neurochem; 1983 May; 40(5):1414-22. PubMed ID: 6300336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of [3H]5-hydroxytryptamine and [3H]spiperone binding sites in clathrin-coated vesicles from bovine brain.
    Moroi K; Ozaki N; Kadota T; Kadota K
    Brain Res; 1998 Jun; 794(2):291-8. PubMed ID: 9622654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ontogeny of diurnal rhythms of central dopamine, serotonin and spirodecanone binding sites and of motor activity in the rat.
    Bruinink A; Lichtensteiger W; Schlumpf M
    Life Sci; 1983 Jul; 33(1):31-8. PubMed ID: 6306372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ontogeny of dopamine, serotonin and spirodecanone receptors in rat forebrain--an autoradiographic study.
    Murrin LC; Gibbens DL; Ferrer JR
    Brain Res; 1985 Nov; 355(1):91-109. PubMed ID: 4075109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laminar distribution of receptors in monkey (Macaca fascicularis) geniculostriate system.
    Shaw C; Cynader M
    J Comp Neurol; 1986 Jun; 248(3):301-12. PubMed ID: 3013949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential photoaffinity labelling of serotonin-S2 receptors and histamine-H1 receptors using 7-azidoketanserin.
    Wouters W; Van Dun J; Leysen JE; Laduron PM
    FEBS Lett; 1985 Mar; 182(2):291-6. PubMed ID: 3979551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor alterations in subcortical structures after bilateral middle cerebral artery infarction of the cerebral cortex.
    Dawson VL; Hsu CY; Liu TH; Dawson TM; Wamsley JK
    Exp Neurol; 1994 Jul; 128(1):88-96. PubMed ID: 8070526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the methylxanthine derivative pentoxifylline on benzodiazepine and muscarinic binding sites in rat cerebral cortex.
    Lowenstein PR; Aguilar JS; Sabato UC
    Acta Physiol Pharmacol Latinoam; 1985; 35(4):431-9. PubMed ID: 3012947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigations on the binding properties of the nootropic agent pyroglutamic acid.
    Barone D; Spignoli G
    Drugs Exp Clin Res; 1990; 16(2):85-99. PubMed ID: 1976055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.